Kamada (KMDA) Other Working Capital Changes (2014 - 2026)
Kamada (KMDA) posted quarterly Other Working Capital Changes of $144000.0 for Q4 2025, up 2.86% year-on-year from $140000.0 in Q4 2024, and up 2.86% on a QoQ basis from $140000.0 in Q4 2024.
Kamada (KMDA) Other Working Capital Changes (2014 - 2026) Analysis & Trends
Kamada (KMDA) has reported Other Working Capital Changes for 14 consecutive years, with $144000.0 the latest figure, recorded in Q4 2025.
- Quarterly Other Working Capital Changes rose 2.86% year-over-year to $144000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $334977.0 (up 276.28% YoY) and the FY2025 annual result came in at $475000.0, changed 0.21% from the prior year.
- Other Working Capital Changes improved to $144000.0 in Q4 2025 per KMDA's latest filing, from $140000.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for KMDA reached as high as $845000.0 in Q3 2025 and fell as low as -$1.0 million in Q4 2025.
- A 4-year average of -$27047.4 and a median of $1000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes slumped 107.55% — and 2023, when it surged 255100.0%.
- Year by year, Other Working Capital Changes stood at $265.0 in 2021, then sank by 107.55% to -$20.0 in 2022, then jumped by 255100.0% to $51000.0 in 2023, then soared by 174.51% to $140000.0 in 2024, then gained by 2.86% to $144000.0 in 2025.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered $144000.0, $140000.0, and $51000.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67,000.00 |
| Mar 31, 2026 | 67,000.00 |
| Mar 31, 2026 | 67,000.00 |
| Dec 31, 2025 | -1.02 Mn |
| Dec 31, 2025 | -1.02 Mn |
| Dec 31, 2025 | -1.02 Mn |
| Sep 30, 2025 | 845,000.00 |
| Sep 30, 2025 | 845,000.00 |
| Sep 30, 2025 | 845,000.00 |
| Jun 30, 2025 | -28,000.00 |
| Jun 30, 2025 | -28,000.00 |
| Jun 30, 2025 | -28,000.00 |
| Mar 31, 2025 | 34,000.00 |
| Mar 31, 2025 | 34,000.00 |
| Mar 31, 2025 | 34,000.00 |
| Dec 31, 2024 | 130,000.00 |
| Dec 31, 2024 | 130,000.00 |
| Dec 31, 2024 | 130,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Sep 30, 2024 | 14,000.00 |